The pharmaceutical industry is accelerating its adoption of AI agents for various applications, raising questions about whether the pace of implementation is outpacing adequate safety and validation protocols. Industry experts are debating the balance between leveraging AI’s potential benefits and ensuring sufficient testing before deployment in critical pharmaceutical processes.